Oxygen Therapy Market to Reach US$ 10.06 Billion by 2033 at 8.9% CAGR, Driven by Oxygen Concentrators (35%), COPD & Asthma (55% Combined), North America (35% Share), and Key Players Including Medtronic plc, Philips Healthcare (Koninklijke Philips N.V.), R

The Oxygen Therapy Market size reached US$ 4.69 Billion in 2024 and is expected to reach US$ 10.06 Billion by 2033, growing at a CAGR of 8.9% from 2025 to 2033. as healthcare providers and patients increasingly adopt supplemental oxygen solutions to manage chronic respiratory conditions and acute care needs.
Growth is supported by rising demand across key product segments such as stationary oxygen concentrators, portable oxygen concentrators, compressed gas cylinders, liquid oxygen systems, and accessories, driven by the increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, COVID‐19‐related respiratory complications, and other hypoxemic conditions. Integration of advanced technologies including lightweight portable designs, improved battery performance, and smart monitoring features further accelerates market adoption by enhancing patient mobility and ease of use. Additionally, expanding home healthcare services, growing geriatric populations, and heightened focus on early diagnosis and long‐term management of respiratory illnesses continue to propel broad utilization of oxygen therapy solutions worldwide.

Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/oxygen-therapy-market?sindhuri

Oxygen Therapy Market: Competitive Intelligence
Medtronic plc, Philips Healthcare (Koninklijke Philips N.V.), ResMed Inc., GE HealthCare, Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare, Smiths Medical (ICU Medical, Inc.), Chart Industries, Inc., O2 Concepts LLC, and others.
The Oxygen Therapy Market is strongly driven by leading medical device and respiratory care solution providers such as Medtronic plc, Philips Healthcare, ResMed Inc., GE HealthCare, and Fisher & Paykel Healthcare Corporation Limited, who develop and supply a wide range of oxygen delivery and therapy systems including stationary and portable oxygen concentrators, liquid oxygen systems, high‐flow nasal cannula systems, ventilator‐integrated oxygen therapy products, and homecare devices that support treatment of hypoxemia associated with chronic respiratory diseases, acute respiratory distress, surgical recovery, and other clinical conditions across hospital, clinic, and home‐care settings.
Increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, COVID‐19 and post‐COVID respiratory complications, cardiovascular disorders, and other respiratory impairments requiring supplemental oxygen are key factors fueling market demand. Additionally, ageing populations, expanding access to home‐based care, and advancements in wearable and portable oxygen delivery technologies are supporting broader adoption of oxygen therapy solutions across both developed and emerging healthcare markets.
These companies' complementary strengths comprehensive respiratory and critical care portfolios from Medtronic and Philips; specialized sleep and oxygen therapy devices from ResMed; integrated patient monitoring and imaging‐linked oxygen systems from GE HealthCare; innovative humidification and interface solutions from Fisher & Paykel Healthcare; portable and homecare‐focused offerings from Drive DeVilbiss Healthcare and O2 Concepts; and acute‐care consumable support from Smiths Medical and Chart Industries enhance competitive positioning across clinical and home‐based applications. Strategic focus areas include development of lightweight and energy‐efficient portable concentrators, enhanced high‐flow and hybrid oxygen delivery systems, digital connectivity and remote patient monitoring integration, partnerships with healthcare providers and home‐care networks, and expansion into high‐growth regions with rising respiratory disease burdens and ageing populations.

Get Customization in the report as per your requirements:
https://www.datamintelligence.com/customize/oxygen-therapy-market?sindhuri

Recent Key Developments - United States & North America
✅ June 2025: Philips Healthcare expanded its portfolio of home and hospital oxygen therapy systems with portable and high-flow oxygen concentrators for chronic respiratory disease management.
✅ May 2025: Invacare Corporation launched next-generation oxygen delivery devices featuring smart connectivity, enabling remote monitoring of patient adherence and oxygen saturation levels.
✅ 2025: Rising prevalence of COPD, COVID-19-related lung complications, and other chronic respiratory conditions drove increased adoption of oxygen therapy solutions across hospitals, home care, and rehabilitation centers.

Recent Key Developments - Europe
✅ July 2025: Fisher & Paykel Healthcare expanded European distribution of high-flow nasal cannula and non-invasive oxygen therapy devices, supporting critical care and emergency departments.
✅ Early 2026: ResMed introduced compact, energy-efficient portable oxygen concentrators for European home healthcare users, enhancing mobility and adherence.
✅ 2025: European healthcare providers increasingly adopted smart oxygen therapy systems to improve patient outcomes and reduce hospital readmissions.

Recent Key Developments - Asia-Pacific
✅ June 2025: Terumo Corporation launched advanced oxygen delivery devices in Japan and Southeast Asia, integrating real-time patient monitoring and humidification systems for neonates and adult patients.
✅ 2025: Mindray Medical International scaled up production and distribution of portable and hospital-grade oxygen therapy devices to meet growing demand from acute respiratory care and home care markets in China, India, and Australia.
✅ 2025-2026: Rising incidence of respiratory diseases, aging populations, and government initiatives for improved critical care infrastructure fueled market growth in Asia-Pacific.

Recent Key Developments - Product & Technology Innovation
✅ High-Flow & Portable Oxygen Systems: Development of lightweight, battery-powered, and high-flow concentrators for both hospital and home use.
✅ Smart Connectivity & Monitoring: Integration of IoT and digital platforms for remote monitoring of oxygen saturation, device usage, and predictive maintenance.
✅ Non-Invasive & Hybrid Delivery Devices: Innovations in nasal cannulas, masks, and combined non-invasive ventilation systems enhance patient comfort and clinical outcomes.

✅ 1. M&A / Strategic Activity
Recent strategic acquisitions and collaborations shaping the oxygen therapy market:
ResMed - Expansion of respiratory care portfolio
ResMed continued to strengthen its respiratory care offerings, including oxygen therapy devices, through acquisitions and partnerships with companies that expand telehealth capabilities and remote patient monitoring - enhancing integrated care for chronic respiratory patients.
Philips Respironics - Strategic partnerships for home health solutions
Philips Respironics expanded alliances with home healthcare service providers to broaden access to oxygen concentrator devices and associated support services, especially in North America and Europe.
Invacare Corporation - Distribution network expansions
Invacare partnered with regional distributors in APAC and Latin America to increase availability of portable and home oxygen concentrators, expanding its presence in emerging and underserved markets.
Medtronic - Collaborations with healthcare systems
Medtronic entered collaborations with hospital networks to deploy advanced oxygen delivery systems in outpatient and acute care settings, aligning with post‐acute care trends and integrated respiratory management pathways.

✅ 2. New Product Launches & Regulatory Milestones
Recent product introductions and regulatory developments in oxygen therapy:
ResMed - AirSenseTM with integrated oxygen support
ResMed launched an updated AirSenseTM platform compatible with integrated oxygen delivery modules that allow clinicians to titrate supplemental oxygen alongside positive airway pressure therapy for patients with co‐morbid respiratory conditions.
Philips - Portable Oxygen Concentrator Upgrades
Philips introduced an upgraded line of portable oxygen concentrators featuring lightweight design, extended battery life, and intelligent oxygen dosing algorithms to support active and homebound patients.
Invacare - Next‐Gen Home Oxygen Systems
Invacare released new home oxygen concentrators equipped with quiet operation, improved energy efficiency, and user‐friendly interfaces, enhancing long‐term compliance and patient comfort.
Fisher & Paykel Healthcare - Clinical Oxygen Delivery Interfaces
Fisher & Paykel expanded its clinical oxygen delivery solutions with advanced interfaces and humidified oxygen circuits designed for acute and critical care use, improving patient comfort and reducing mucosal dryness.
Regulatory Updates - Telehealth Oxygen Titration Guidance
Regulatory agencies, including the U.S. CDC and CMS, updated guidance supporting remote oxygen monitoring and home titration protocols, enabling broader adoption of telehealth‐enabled oxygen therapy models.

✅ 3. R&D & Technological Advancements
Smart & Connected Oxygen Delivery Systems
R&D is focusing on IoT‐enabled oxygen therapy devices that integrate with digital platforms for remote monitoring of usage, SpO2 levels, and adherence - improving clinician oversight and patient outcomes.
Pulse Dose & Adaptive Delivery Technologies
Emerging technologies emphasize adaptive oxygen delivery (e.g., pulse dose modulation and sensor‐guided titration) that optimize oxygen administration based on patient activity and physiological needs.
Lightweight & Efficient Portable Units
Advancements in compressor design, energy recovery, and lightweight materials are enabling longer battery life and reduced weight for portable oxygen concentrators, enhancing patient mobility.
Integration with Telehealth & Mobile Apps
Mobile applications tied to oxygen therapy devices support real‐time tracking, alerts, and clinician connectivity, making oxygen therapy more personalized and accessible outside traditional care settings.

Market Drivers & Emerging Trends
» Rising Prevalence of Respiratory Diseases - Increasing COPD, pulmonary fibrosis, and sleep‐related breathing disorders drive demand for supplemental oxygen therapy.
» Aging Population & Chronic Care Needs - Older adults with chronic cardiopulmonary conditions represent a growing user base for long‐term oxygen therapy.
» Post‐Acute & Home Healthcare Expansion - Shift toward home‐based respiratory care accelerates adoption of portable and user‐friendly oxygen devices.
» Telehealth & Remote Monitoring Integration - Connectivity and remote care support enhance compliance, reduce hospital visits, and improve therapy management.
» Emerging Market Growth - Improved healthcare infrastructure and rising awareness in APAC, Latin America, and MENA regions fuel market expansion.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=oxygen-therapy-market?sindhuri

Segments Covered in the Oxygen Therapy Market:
By Product
The market is segmented into oxygen source equipment (30%), oxygen concentrators (35%), oxygen cylinders (20%), liquid oxygen tanks (10%), and others (5%).Oxygen concentrators dominate due to their ease of use, cost-effectiveness, and increasing adoption for home-based therapy. Oxygen source equipment is widely used in hospitals and clinical settings for continuous supply. Oxygen cylinders are important for portability and emergency use, while liquid oxygen tanks cater to high-flow applications and critical care. The "others" segment includes portable oxygen delivery systems and accessories.

By Application
Applications include chronic obstructive pulmonary disease (COPD) (35%), asthma (20%), obstructive sleep apnea (15%), pneumonia (10%), and others (20%).COPD dominates due to its high prevalence and long-term oxygen therapy requirements. Asthma and obstructive sleep apnea are growing applications for home and clinical therapy devices. Pneumonia contributes to hospital-based oxygen demand, especially during acute respiratory infections. The "others" segment includes bronchitis, pulmonary fibrosis, and COVID-19-related oxygen therapy.

By End-User
End-users include hospitals and clinics (55%), home healthcare (35%), and others (10%).Hospitals and clinics dominate due to critical care needs, surgical procedures, and emergency respiratory support. Home healthcare is rapidly growing due to increasing prevalence of chronic respiratory diseases and aging populations. Others include rehabilitation centers and specialized respiratory therapy facilities.

Regional Analysis
North America - 35% Share
North America leads due to well-established healthcare infrastructure, high prevalence of chronic respiratory diseases, and strong adoption of home healthcare solutions in the U.S. and Canada.

Europe - 25% Share
Europe holds a significant share supported by growing awareness of respiratory disorders, advanced medical facilities, and increasing adoption of oxygen therapy devices in Germany, the U.K., France, and Italy.

Asia-Pacific - 25% Share
Asia-Pacific is witnessing rapid growth due to rising respiratory disease prevalence, expanding healthcare access, and increasing investments in home healthcare in China, India, Japan, and South Korea.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sindhuri
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.